Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors

Transfusion

Volumn 36, Issue 1, 1996, Pages 37-44

  Busch, M P ^a,b   Kleinman, S H ^c,d   Williams, A E ^e   Smith, J W ^f   Ownby, H E ^g   Laycock, M E ^h,i   Lee, L L L ⁱ   Pau, C P ^j   Schreiber, G B ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Blood Centers of the Pacific   (United States)

^c Dept of Pathol and Lab Medicine ^*

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOLLAND LABORATORY   (United States)

^f Oklahoma Blood Institute   (United States)

^g AMERICAN RED CROSS BLOOD SERVICES   (United States)

^h WESTAT   (United States)

ⁱ Irwin Memorial Blood Centers

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; SEROCONVERSION;

ADULT; BLOOD DONORS; BLOTTING, WESTERN; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HIV-2; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RNA, VIRAL; TIME FACTORS;

EID: 0030065080     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36196190513.x     Document Type: Article

References (34)

1. Kleinman S. The significance of HIV-1-indeterminate western blot results in blood donor populations. Arch Pathol Lab Med 1990;114:298-303.
2. Dodd R, Fang C. The western immunoblot procedure for HIV antibodies and its interpretation. Arch Pathol Lab Med 1990;114:240-5.
3. Celum CL, Coombs RW, Lafferty W, et al. Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J Infect Dis 1991;164:656-64.
4. Lefrere JJ, Courouce AM, Lucotte G, et al. Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS 1988;2:287-90.
5. Van der Poel C, Lelie P, Reesink H, et al. Blood donors with indeterminate anti-p24 gag reactivity in HIV-1 western blot: absence of infectivity to transfused patients and in virus culture. Vox Sang 1989;56:162-7.
6. Jackson JB, MacDonald KL, Cadwell J, et al. Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1. N Engl J Med 1990;322:217-22.
7. Mariotti M, Rouger P, Thauvin M, et al. Failure to detect evidence of human immunodeficiency virus type 1 (HIV-1) infection by polymerase chain reaction assay in blood donors with isolated core antibodies (anti-p24 or -p17) to HIV-1. Transfusion 1990;30:704-6.
8. Dock NL, Kleinman SH, Rayfield MA, et al. Human immunodeficiency virus infection and indeterminate western blot patterns. Prospective studies in a low prevalence population. Arch Intern Med 1991;151:525-30.
9. Eble BE, Busch MP, Khayam-Bashi H, et al. Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence area Transfusion 1992;32:503-8.
10. Coombs RW, Henrard DR, Mehaffey WF, et al. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol 1993;31:1980-6.
11. Revised recommendations for the prevention of human immunodeficiency virus (HIV) transmission by blood and blood products. Bethesda: Center for Biologies Evaluation and Research, Food and Drug Administration, April 23, 1993.
12. Henrard DR, Phillips J, Windsor I, et al. Detection of human immunodeficiency virus type 1 p24 antigen and plasma RNA: relevance to indeterminate serologic tests. Transfusion 1994;34:376-80.
13. Courouce AM, Barin F, Maniez M, et al. Effectiveness of assays for antibodies to HIV and p24 antigen to detect very recent HIV infections in blood donors. The Retrovirus Study Group of the French Society of Blood Transfusion (letter). AIDS 1992;6:1548-50.
14. Ness PM, Douglas D, Koziol D, et al. Decreasing seroprevalence of human immunodeficiency virus type 1 in a regional blood donor population. Transfusion 1990;30:201-6.
15. Petersen LR, Doll LS, White CR, et al. Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors. HIV Blood Donor Study Group. Transfusion 1993;33:552-7.
16. Busch MP, Lee LLL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
17. Simon F, Pepin JM, Brun-Vezinet F, et al. Reliability of western blotting for the confirmation of HIV-1 seroconversion (letter). Lancet 1992;340:1541-2.
18. Soriano V, Gutiérrez M, Heredia A, et al. Evaluation of different supplementary assays for the confirmation of HIV-1 and HIV-2 infections (letter). Vox Sang 1994;66:82-3.
19. Interpretive criteria used to report western blot results for HIV-1-antibody testing - United States. MMWR Morb Mortal Wkly Rep 1991;40:692-5.
20. Jurgensen P, Evans J, Skora C, et al. HIV-2: effect on specificity (abstract). Transfusion 1994;34(Suppl):44S.
21. Gallarda JL, Henrard DR, Liu D, et al. Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of IgM antibody. J Clin Microbiol 1992;30:2379-84.
22. Zaaijer HL, van Exel-Oehlers P, Kraaijeveld T, et al. Early detection of antibodies to HIV-1 by third-generation assays. Lancet 1992;340:770-2.
23. O'Brien TR, George JR, Holmberg SD. Human immunodeficiency virus type 2 infection in the United States. Epidemiology, diagnosis, and public health implications. JAMA 1992;267:2775-9.
24. Loussert-Ajaka I, Ly TD, Chaix ML, et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-4.
25. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-4.
26. Schreiber GB, Busch MP, Gilcher RO, et al. Incidence rates of infectious disease markers in repeat blood donors (abstract). Transfusion 1994;34(Suppl):71S.
27. Jackson JB, Ndugwa C, Mmiro F, et al. Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants. AIDS 1991;5:1463-7.
28. Mulder J, McKinney N, Christopherson C, et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
29. Henrard DR, Phillips J, Phelps BH, et al. Detection of HIV p24 antigen and plasma RNA can identify true HIV-1 infection among EIA-reactive/seroindeterminate specimens (abstract). Vox Sang 1994;67(Suppl 2):30.
30. MacKenzie WR, Davis JP, Peterson DE, et al. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA 1992;268:1015-7.
31. Healey DS, Bolton WV. Apparent HIV-1 glycoprotein reactivity on western blot in uninfected blood donors. AIDS 1993;7:655-8.
32. Sayre KR, Dodd RY, Tegtmeier G, et al. False-positive human immunodeficiency virus type 1 Western blot tests in noninfected blood donors. Transfusion 1996;36:45-52.
33. Genesca J, Shih JW, Jett BW, et al. What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet 1989;2:1023-5.
34. Jackson JB, Hanson MR, Johnson GM, et al. Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot. Transfusion 1995;35:98-102.